Yahoo
OTC Markets OTCID USD

Lee Pharmaceuticals, Inc. (AIMN)

0.0013 0.0000 (0.00%)
At close: October 23 at 4:00:00 PM EDT
Chart Range Bar
Loading chart for AIMN
  • Previous Close 0.0013
  • Open 0.0012
  • Bid 0.0010 x 222014500
  • Ask 0.0012 x 1000000
  • Day's Range 0.0010 - 0.0013
  • 52 Week Range 0.0005 - 6.0000
  • Volume 2,441,098
  • Avg. Volume 6,375,067
  • Market Cap (intraday) 429,177
  • Beta (5Y Monthly) 12.71
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Aimwell Partners Inc. focuses on the design and development, manufacture, marketing, and sale of all-electric, hydrogen-fuel cell, and zero-emission new energy vehicles (NEVs) in the United States, China, and internationally. It intends to offer hydrogen fuel cell NEVs, including sports cars, sedans, SUVs, trucks, and buses. The company was formerly known as RONN Inc. and changes its name to Aimwell Partners Inc. in March 2026. Aimwell Partners Inc. was founded in 2013 and is based in Scottsdale, Arizona.

www.ronnmotorgroup.com

1

Full Time Employees

December 31

Fiscal Year Ends

Shell Companies

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/26/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

AIMN
99.98%
S&P 500 (^GSPC)
12.14%

1-Year Return

AIMN
99.98%
S&P 500 (^GSPC)
13.03%

3-Year Return

AIMN
100.00%
S&P 500 (^GSPC)
85.55%

5-Year Return

AIMN
100.00%
S&P 500 (^GSPC)
67.81%

Statistics

View More

Valuation Measures

Annual
As of 10/23/2026
  • Market Cap

    429.18k

  • Enterprise Value

    429.18k

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -1,670.94%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -505.11k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    233.49k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: